Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kin-Ming Lo

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
Immunogenicity of the hu14.18-IL2 immunocytokine molecule in adults with melanoma and children with neuroblastomaJacquelyn A Hank, Jacek Gan, Hyunji Ryu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2014
Cutting edge: epigenetic regulation of Foxp3 defines a stable population of CD4+ regulatory T cells in tumors from mice and humansJeremy D Waight, Shinji Takai, Bo Marelli, et al.
The Journal of Pediatrics|July 22, 2018
Linking Healthcare and Social Service Databases to Study the Epidemiology of Child Maltreatment and Associated Health Problems: Hong Kong's ExperienceCamilla Kin-Ming Lo, Frederick Ka-Wing Ho, Ko Ling Chan, et al.
Protein Engineering, Design & Selection : PEDS|April 12, 2005
Improvement of Fc-erythropoietin structure and pharmacokinetics by modification at a disulfide bondJeffrey C Way, Scott Lauder, Beatrice Brunkhorst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Combination Therapy with NHS-muIL12 and Avelumab (anti-PD-L1) Enhances Antitumor Efficacy in Preclinical Cancer ModelsChunxiao Xu, Yanping Zhang, P Alexander Rolfe, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 29, 2004
The development of a modified human IFN-alpha2b linked to the Fc portion of human IgG1 as a novel potential therapeutic for the treatment of hepatitis C virus infectionTim D Jones, Marian Hanlon, Beverley J Smith, et al.
Science Translational Medicine|January 19, 2018
Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-βYan Lan, Dong Zhang, Chunxiao Xu, et al.
Journal of Virology|December 3, 2003
Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridgeNikolay Korokhov, Galina Mikheeva, Alexander Krendelshchikov, et al.
Journal for Immunotherapy of Cancer|July 20, 2022
Colocalized targeting of TGF-β and PD-L1 by bintrafusp alfa elicits distinct antitumor responsesYan Lan, Tsz-Lun Yeung, Hui Huang, et al.
Cancer Cell|September 10, 2021
Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasionYan Lan, Mahmoud Moustafa, Maximilian Knoll, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
Immunogenicity of the hu14.18-IL2 immunocytokine molecule in adults with melanoma and children with neuroblastomaJacquelyn A Hank, Jacek Gan, Hyunji Ryu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2014
Cutting edge: epigenetic regulation of Foxp3 defines a stable population of CD4+ regulatory T cells in tumors from mice and humansJeremy D Waight, Shinji Takai, Bo Marelli, et al.
The Journal of Pediatrics|July 22, 2018
Linking Healthcare and Social Service Databases to Study the Epidemiology of Child Maltreatment and Associated Health Problems: Hong Kong's ExperienceCamilla Kin-Ming Lo, Frederick Ka-Wing Ho, Ko Ling Chan, et al.
Protein Engineering, Design & Selection : PEDS|April 12, 2005
Improvement of Fc-erythropoietin structure and pharmacokinetics by modification at a disulfide bondJeffrey C Way, Scott Lauder, Beatrice Brunkhorst, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Combination Therapy with NHS-muIL12 and Avelumab (anti-PD-L1) Enhances Antitumor Efficacy in Preclinical Cancer ModelsChunxiao Xu, Yanping Zhang, P Alexander Rolfe, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 29, 2004
The development of a modified human IFN-alpha2b linked to the Fc portion of human IgG1 as a novel potential therapeutic for the treatment of hepatitis C virus infectionTim D Jones, Marian Hanlon, Beverley J Smith, et al.
Science Translational Medicine|January 19, 2018
Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-βYan Lan, Dong Zhang, Chunxiao Xu, et al.
Journal of Virology|December 3, 2003
Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridgeNikolay Korokhov, Galina Mikheeva, Alexander Krendelshchikov, et al.
Journal for Immunotherapy of Cancer|July 20, 2022
Colocalized targeting of TGF-β and PD-L1 by bintrafusp alfa elicits distinct antitumor responsesYan Lan, Tsz-Lun Yeung, Hui Huang, et al.
Cancer Cell|September 10, 2021
Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasionYan Lan, Mahmoud Moustafa, Maximilian Knoll, et al.
Pageof 5